Total Payments
$33,621
2024 Payments
$992.59
Companies
18
Transactions
74
Payment Breakdown by Category
Research$28,370 (84.4%)
Travel$2,359 (7.0%)
Food & Beverage$1,916 (5.7%)
Consulting$975.00 (2.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $28,370 | 6 | 84.4% |
| Travel and Lodging | $2,359 | 8 | 7.0% |
| Food and Beverage | $1,916 | 59 | 5.7% |
| Consulting Fee | $975.00 | 1 | 2.9% |
Payments by Type
Research
$28,370
6 transactions
General
$5,251
68 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $30,145 | 21 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,485 | 13 | $0 (2022) |
| Verrica Pharmaceuticals Inc. | $1,286 | 6 | $0 (2024) |
| SANOFI PASTEUR INC. | $202.65 | 4 | $0 (2021) |
| Shire North American Group Inc | $146.16 | 9 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $73.57 | 4 | $0 (2018) |
| Tris Pharma Inc | $49.04 | 3 | $0 (2021) |
| Genentech USA, Inc. | $47.35 | 1 | $0 (2018) |
| Ironshore Pharmaceuticals Inc. | $34.84 | 2 | $0 (2019) |
| kaleo, Inc. | $24.14 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $992.59 | 2 | Verrica Pharmaceuticals Inc. ($975.00) |
| 2023 | $28,552 | 12 | PFIZER INC. ($28,222) |
| 2022 | $28.87 | 2 | Merck Sharp & Dohme LLC ($16.85) |
| 2021 | $78.22 | 6 | PFIZER INC. ($21.31) |
| 2020 | $26.17 | 2 | PFIZER INC. ($13.99) |
| 2019 | $1,944 | 16 | PFIZER INC. ($1,835) |
| 2018 | $1,706 | 24 | Merck Sharp & Dohme Corporation ($1,451) |
| 2017 | $291.88 | 10 | SANOFI PASTEUR INC. ($188.84) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: VACCINES | ||||||
| 03/01/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Consulting Fee | Cash or cash equivalent | $975.00 | General |
| Category: DERMATOLOGY | ||||||
| 12/27/2023 | PFIZER INC. | NURTEC ODT (Drug) | — | Cash or cash equivalent | $8,061.70 | Research |
| Study: PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND GROUP SEQUENTIAL PLACEBOCONTROLLED STUDY TO ASSESS EFFICACY AND SAFETY OF RIMEGEPANT FOR THE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN CHILDREN AND ADOLESCENTS 6 TO 18 YEARS OF AGE • Category: PAIN | ||||||
| 12/11/2023 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: VACCINES | ||||||
| 12/07/2023 | PFIZER INC. | NURTEC ODT (Drug) | — | Cash or cash equivalent | $1,371.46 | Research |
| Study: PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND GROUP SEQUENTIAL PLACEBOCONTROLLED STUDY TO ASSESS EFFICACY AND SAFETY OF RIMEGEPANT FOR THE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN CHILDREN AND ADOLESCENTS 6 TO 18 YEARS OF AGE • Category: PAIN | ||||||
| 12/07/2023 | PFIZER INC. | NURTEC ODT (Drug) | — | Cash or cash equivalent | $1,262.02 | Research |
| Study: PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND GROUP SEQUENTIAL PLACEBOCONTROLLED STUDY TO ASSESS EFFICACY AND SAFETY OF RIMEGEPANT FOR THE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN CHILDREN AND ADOLESCENTS 6 TO 18 YEARS OF AGE • Category: PAIN | ||||||
| 12/01/2023 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: VACCINES | ||||||
| 11/01/2023 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $110.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/01/2023 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $41.46 | General |
| Category: DERMATOLOGY | ||||||
| 10/30/2023 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: DERMATOLOGY | ||||||
| 10/12/2023 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: DERMATOLOGY | ||||||
| 10/11/2023 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $123.19 | General |
| Category: DERMATOLOGY | ||||||
| 08/03/2023 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $19.00 | General |
| 05/25/2023 | PFIZER INC. | NURTEC ODT (Drug) | — | Cash or cash equivalent | $17,500.00 | Research |
| Study: PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND GROUP SEQUENTIAL PLACEBOCONTROLLED STUDY TO ASSESS EFFICACY AND SAFETY OF RIMEGEPANT FOR THE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN CHILDREN AND ADOLESCENTS 6 TO 18 YEARS OF AGE • Category: PAIN | ||||||
| 02/21/2022 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: Allergy | ||||||
| 02/07/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), ROTATEQ, VAXELIS | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: VACCINE | ||||||
| 12/07/2021 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: ALLERGY | ||||||
| 10/07/2021 | PFIZER INC. | PREVNAR 13 (Biological), TRUMENBA | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: VACCINES | ||||||
| 09/29/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), ROTATEQ, VAXELIS | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: VACCINE | ||||||
| 07/18/2021 | PFIZER INC. | PREVNAR 13 (Biological), TRUMENBA | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: VACCINES | ||||||
| 06/08/2021 | SANOFI PASTEUR INC. | VAXELIS (Biological) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Vaccines | ||||||
| 05/19/2021 | Tris Pharma Inc | Quillivant (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: ADHD | ||||||
| 02/06/2020 | Tris Pharma Inc | Quillichew ER (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: ADHD | ||||||
| 01/28/2020 | PFIZER INC. | PREVNAR 13 (Biological), TRUMENBA | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: VACCINES | ||||||
| 09/30/2019 | Ironshore Pharmaceuticals Inc. | Jornay PM 20mg capsules (Bottle of 100) (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Central nervous system (CNS) stimulant | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND GROUP SEQUENTIAL PLACEBOCONTROLLED STUDY TO ASSESS EFFICACY AND SAFETY OF RIMEGEPANT FOR THE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN CHILDREN AND ADOLESCENTS 6 TO 18 YEARS OF AGE | PFIZER INC. | $28,195 | 4 |
| Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults and Older Adults | SANOFI PASTEUR INC. | $175.00 | 2 |
About Dr. Bradford Brabec, MD
Dr. Bradford Brabec, MD is a Pediatrics healthcare provider based in Lincoln, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1700863826.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bradford Brabec, MD has received a total of $33,621 in payments from pharmaceutical and medical device companies, with $992.59 received in 2024. These payments were reported across 74 transactions from 18 companies. The most common payment nature is "" ($28,370).
Ad
Practice Information
- Specialty Pediatrics
- Location Lincoln, NE
- Active Since 12/29/2005
- Last Updated 07/29/2022
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1700863826
Products in Payments
- NURTEC ODT (Drug) $28,195
- V114 (Biological) $1,442
- YCANTH (Drug) $1,286
- NO PRODUCT DISCUSSED (Drug) $175.00
- VYVANSE (Drug) $110.86
- PREVNAR - 13 (Biological) $55.67
- Xolair (Biological) $47.35
- PREVNAR 20 (Biological) $44.63
- FLUMIST (Drug) $39.30
- PREVNAR 13 (Biological) $35.30
- MYDAYIS (Drug) $35.30
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $34.84
- SYNAGIS (Biological) $34.27
- GARDASIL 9 (Biological) $29.98
- AUVI-Q (Drug) $24.14
- Dymista (Drug) $23.21
- Synagis (Drug) $19.71
- Dyanavel XR (Drug) $19.01
- Quillivant (Drug) $17.85
- Vyvanse (Drug) $15.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Lincoln
Karen Madras, Md, MD
Pediatrics — Payments: $19,823
Pediatrics $19,823
Dr. David Meduna, Md, MD
Pediatrics — Payments: $11,713
Pediatrics $11,713
Sahra Niazi, Md, MD
Pediatrics — Payments: $6,841
Pediatrics $6,841
Dr. Paul Bernhardson, M.d, M.D
Pediatrics — Payments: $6,312
Pediatrics $6,312
Luke Anschutz, M.d, M.D
Pediatrics — Payments: $5,179
Pediatrics $5,179
Kristen Speaker, Np, NP
Pediatrics — Payments: $3,149
Pediatrics $3,149